Email Updates

You are here

Home

25 SEPTEMBER 2020 VOLUME 22 ISSUE 37

Media Coverage

  • First Man Cured of HIV Infection Now Has Terminal Cancer

    Timothy Ray Brown, the first person known to have been cured of HIV infection, says he is now terminally ill from a recurrence of the cancer that prompted his historic treatment 12 years ago.

    September 25, 2020
    General
    AP

  • HIV Diagnoses Decline Among Gay and Bi Men, Largely Driven by Whites

    As the annual rate of HIV diagnosis among men who have sex with men (MSM) declined by an average of 2.3 percent annually between 2014 and 2018, among Black and Latino men and teenagers, the rate largely remained stable or declined by a smaller proportion than among white men.

    September 25, 2020
    General
    POZ

  • Science, Not Politics, Must Lead to COVID Vaccine Approvals

    COVID-19 has devastated communities and health systems around the world – but it has also created an historic global effort leading to the unprecedented development of more than 165 potential vaccines against COVID-19. Equally impressive innovations are speeding vaccine testing within a rigorous scientific framework, while manufacturing and transportation capacity are being scaled up to distribute millions of doses of future COVID vaccines to those who need them most.

    September 24, 2020
    General
    Science Speaks

  • Are Monoclonal Antibodies the Future of COVID-19 Treatment?

    In August, the National Institutes of Health (NIH), the foremost medical and public health research agency in the US, announced a clinical trial to evaluate the efficacy and safety of potential new therapeutics for COVID-19, including monoclonal antibodies to treat the disease. The trial, known as ACTIV-2, is funded by the National Institute of Allergy and Infectious Diseases (NIAID) through “Operation Warp Speed,” a partnership led by the US Department of Health and Human Services (HHS).

    September 24, 2020
    Antibody Related Research
    The BodyPro

  • Educational Efforts Increase Use of HIV Preventive Drug in Africa by 55 Percent

    A promotional program designed to educate patients on HIV risk and prevention saw use of a preventive drug regimen among at-risk groups in Africa increase by more than 50 percent, according to a study published Wednesday by the journal Science Translational Medicine.

    September 23, 2020
    PrEP
    UPI

  • COVID-19 Has Created Serious Challenges for Nigeria’s HIV Organizations

    Nigeria recorded its first confirmed COVID-19 case on Feb. 27 in Lagos, in an Italian national on a business venture to Nigeria. Once news circulated, fear crept throughout Lagos and neighboring states. The government initiated preventive policies of quarantining and social distancing and deeply punished those in violation of these orders.

    September 23, 2020
    General
    The Body

  • State HIV Criminalization Laws Tied to Lower PrEP Uptake

    States with laws that criminalize not disclosing being HIV positive prior to sex tend to have a lower PrEP-to-need ratio, which is calculated by dividing the state’s number of pre-exposure prophylaxis (PrEP) users by the number of people diagnosed with the virus in in a single year.

    September 23, 2020
    PrEP
    POZ

  • The Military Is Waging War on HIV-Positive Soldiers

    Kevin Deese joined the US Naval Academy in 2010 with dreams of becoming a distinguished military officer and giving back to the country he loves—just like his Navy pilot brother did. “I wanted to follow in his footsteps and serve our country,” he says. “He was my role model, and I was inspired by his choice to be of service to others. I wanted that for my life, too.”

    September 22, 2020
    General
    Bloomberg Businessweek

  • Framing Mutually Exclusive Concepts To Be Mutually Beneficial In Strategic Communications

    According to the World Health Organization (WHO), there have been over 20 million confirmed cases of COVID-19 and over 700,000 associated deaths throughout the world. These numbers are so staggering that most of society remains shut down until a safe and effective vaccine is brought to market.

    September 21, 2020
    HIV Vaccine
    Forbes

  • WHO Unveils Global Plan to Fairly Distribute COVID-19 Vaccine, but Challenges Await

    The World Health Organization (WHO) announced today that countries representing close to two-thirds of the world’s population have joined its plan to buy and fairly distribute COVID-19 vaccines around the globe. It also unveiled the mechanism through which it plans to allocate the vaccine as it becomes available, aiming “to end the acute phase of the pandemic by the end of 2021.”

    September 21, 2020
    General
    Science Magazine

  • US Entity Raises Age for Boys Cut As It Slashes HIV Funding

    An HIV elimination project funded by the US in Kenya that supports male circumcision as a way of ending HIV and AIDS will now be paying for the circumcision of boys over 15 years only. The US President’s Emergency Plan for AIDS Relief (PEPFAR), the funding entity, said it is unsafe to circumcise boys below that age.

    September 20, 2020
    Voluntary Medical Male Circumcision
    The Standard

  • One in Four Zambian Men Test Positive for HIV in Targeted Testing Initiative

    An innovative initiative that combined community-based HIV testing with 'index testing' – where people who test positive are supported to inform their sexual partners so that they can also test – has reached large numbers of men who didn't know they were living with HIV.

    September 17, 2020
    General
    Avert

  • COVID-19 and HIV: So Far It Seems the Outcome Is Not What Was Feared

    Based on official figures – which may be somewhat under reported – COVID-19 has not been as devastating in South Africa as initially feared.

    September 17, 2020
    General
    The Conversation

Published Research

Announcements